Myeloma cell therapies, now in pharma hands, move into spotlight

Myeloma cell therapies, now in pharma hands, move into spotlight

10 Takeover Targets to Watch This Fall

10 Takeover Targets to Watch This Fall

A Cure for Cancer? How CAR T-Cell Therapy is Revolutionizing Oncology

A Cure for Cancer? How CAR T-Cell Therapy is Revolutionizing Oncology

CAR-T Therapy Development on the Rise

CAR-T Therapy Development on the Rise

Celgene and bluebird bio Rushing to Stay Ahead of the CAR-T Pack

Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!!    Celgene and bluebird bio published interim data from CRB-401, their Phase I trial of bb2121, their CAR-T therapy in patients with relapsed and refractory multiple myeloma. The results were published in the New England Journal of Medicine. In the trial, patients with r/r multiple myeloma who had … Συνεχίστε να διαβάζετε Celgene and bluebird bio Rushing to Stay Ahead of the CAR-T Pack.

Atara Biotherapeutics’ Cancer Drug Might—Might!—Have Applications for MS

Atara Biotherapeutics’ Cancer Drug Might—Might!—Have Applications for MS